ArticleLeukemia2020

UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy.

Johana Díaz-Santa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.